 Valeant Pharmaceuticals International Inc escalating its public campaign to acquire Botoxmaker Allergan Inc threatened to remove members of Allergans board of directors if necessary through a special meeting During a conference call with equity analysts Thursday Valeant Chief Financial Officer Howard Schiller expressed frustration that Allergan hadnt yet entered negotiations with Valeant and Pershing Square Capital Management which last month made an unsolicited  billion bid for Allergan
  